Arvinder Arora
Critical Care Medicine · Effingham, ILNPI 1740294370
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 565 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,934 and has fallen 87.2% since, to $248 in 2025. Among critical care medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 565 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Mylan Specialty L.p.$773
- Lilly USA, LLC$750
- Boehringer Ingelheim$559
- Teva Pharmaceuticals USA, Inc.$520
- Novo Nordisk$476
- plus $4K from 37 others
What the payments were for
- Food & beverage$9,197100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,203 in reported general payments places this provider in the 90th percentile of 281 critical care medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 11 | $9,824 |
| Memantine Hcl | 12 | $1,355 |
| Atorvastatin Calcium | 30 | $361 |
| Losartan Potassium | 25 | $328 |
| Donepezil Hcl | 12 | $206 |
| ClopidogrelClopidogrel Bisulfate | 15 | $164 |
| Metoprolol Tartrate | 16 | $161 |
| Simvastatin | 14 | $149 |
| Clonidine Hcl | 12 | $146 |
| Latanoprost | 14 | $140 |
| Sodium Chloride0.9 % Sodium Chloride | 16 | $132 |
| Furosemide | 17 | $123 |
| Atenolol | 11 | $123 |
| Amlodipine Besylate | 18 | $105 |
| Allopurinol | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Effingham
- Brian ReichardtO Fallon$892K
- Michael CutticaChicago$402K
- Daniel DillingMaywood$208K
- Israel RubinsteinChicago$107K
- John RickelmanQuincy$90K
- Abbas Al-QamariChicago$40K
- Husam NayefPalos Park$24K
- Nureain MirzaOak Lawn$22K
- Edward GarrityBurr Ridge$20K
- Fadi AldaasChicago Ridge$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.